Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
30.44
+0.43 (1.43%)
At close: Mar 30, 2026, 4:00 PM EDT
30.50
+0.06 (0.20%)
After-hours: Mar 30, 2026, 7:36 PM EDT
Veracyte Stock Forecast
Stock Price Forecast
The 6 analysts that cover Veracyte stock have a consensus rating of "Buy" and an average price target of $44.33, which forecasts a 45.63% increase in the stock price over the next year. The lowest target is $37 and the highest is $48.
Price Target: $44.33 (+45.63%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Veracyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +47.83% | Mar 30, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $48 → $37 | Sell | Maintains | $48 → $37 | +21.55% | Mar 6, 2026 |
| Needham | Needham | Strong Buy Maintains $44 → $48 | Strong Buy | Maintains | $44 → $48 | +57.69% | Feb 26, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +64.26% | Jan 5, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $40 → $48 | Sell | Maintains | $40 → $48 | +57.69% | Dec 2, 2025 |
Financial Forecast
Revenue This Year
586.86M
from 517.15M
Increased by 13.48%
Revenue Next Year
661.19M
from 586.86M
Increased by 12.67%
EPS This Year
1.16
from 0.82
Increased by 41.07%
EPS Next Year
1.34
from 1.16
Increased by 15.63%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 609.5M | 697.9M | |||
| Avg | 586.9M | 661.2M | |||
| Low | 548.8M | 618.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.9% | 18.9% | |||
| Avg | 13.5% | 12.7% | |||
| Low | 6.1% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.72 | 1.86 | |||
| Avg | 1.16 | 1.34 | |||
| Low | 0.80 | 0.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 110.0% | 60.7% | |||
| Avg | 41.1% | 15.6% | |||
| Low | -2.0% | -22.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.